Caffeine inhibits STAT1 signaling and downregulates inflammatory pathways involved in autoimmunity

This publication has 45 references indexed in Scilit:

• Blood Monocyte Chemotactic Protein-1 (MCP-1) and Adapted Disease Activity Score28-MCP-1: Favorable Indicators for Rheumatoid Arthritis Activity
  PLOS ONE, 2013
• Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity
  Journal of Autoimmunity, 2012
• Serum levels of selected chemokines in systemic lupus erythematosus patients
  Rheumatology International, 2012
• Identification of a cytokine network sustaining neutrophil and Th17 activation in untreated early rheumatoid arthritis
  Arthritis Research & Therapy, 2010
• The genetics and epigenetics of autoimmune diseases
  Journal of Autoimmunity, 2009
• ToppGene Suite for gene list enrichment analysis and candidate gene prioritization
  Nucleic Acids Research, 2009
• Activation of the interferon‐γ signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells
  Arthritis & Rheumatism, 2009
• Protective effect of caffeine on streptozotocin-induced beta-cell damage in rats
  Journal of Pharmacy and Pharmacology, 2008
• Caffeine Therapy for Apnea of Prematurity
  New England Journal of Medicine, 2006
• Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseases
  Current Opinion in Biotechnology, 2004